Regeneron's Phase III trial investigated cemdisiran and pozelimab as both monotherapies and in combination in gMG.

The ProShares S&P 500 Dividend Aristocrats ETF (NYSEARCA:NOBL) is built for one job: deliver a slowly rising income stream ...

Haisco Pharmaceutical Group Co., Ltd. (Ticker Code: 002653) announced that it has entered into an exclusive licensing agreement with Nuvectis, a U.S. biotechnology company. Under the agreement, Haisco ...

It's put up or shut up time for teams like the Blue Jays and Mariners, while others have to decide on a path forward ...

Nanocurcumin was linked to better disability scores in small RRMS trials, but researchers say larger studies are needed.

$1 million to boost The Haven's Community Center Project. Also, Patterson Foundation commits $500,000 to Suncoast Disaster Recovery Fund.

The transaction transforms Nuvectis into a late-stage clinical development company by expanding its pipeline into complement-mediated diseases ...

In its July 2026 reinsurance renewal report, Guy Carpenter, a global risk and reinsurance specialist and a business of Marsh, ...

Completion of all stages brings the total strategic transaction to approximately $7 million and deepens the companies’ RF technology ...

Fishing is known to be a large contributor of this total; and as recently as 2018, Idaho anglers spent nearly $788 million on ...

The airport is quickly approaching the start of commercial flights following a yearslong push to make passenger service a ...

Every year, hundreds of thousands of people in this country are told something that no one would ever want to hear, ” said ...